Yahoo! Finance Search - Finance Home - Yahoo! - Help

Sunday, December 21 2014 4:59am ET - U.S. Markets Closed.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drugs - Generic News
Latest News
Friday, Dec 19, 2014
·FDA OKs Cubist antibiotic for serious infections
AP - Fri 10:40 pm ET
·Hospira to Present at the J.P. Morgan 33rd Annual Healthcare Conference Jan. 14, 2015
PR Newswire - Fri 4:30 pm ET
·XYDALBA™ (dalbavancin) Receives CHMP Positive Opinion for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in Adults
PR Newswire - Fri 4:15 pm ET
·Parnell Management Adopts 10b5-1 Trading Plans
GlobeNewswire - Fri 3:00 pm ET
·Salix Pharmaceuticals, Ltd. -- Moody's confirms Salix Pharmaceuticals at B1; negative outlook
- Fri 1:45 pm ET
·Akorn to Present at the 33rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Fri 9:30 am ET
·Actavis to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
PR Newswire - Fri 9:00 am ET
·How traders are protecting Mylan
optionMONSTER - Fri 6:16 am ET
·Record Pharma-Deal Year Not Enough to Sell Mature Drugs
at Bloomberg - Fri Dec 19
Thursday, Dec 18, 2014
·Great Stocks: Mallinckrodt Rebounds, But Is It A Buy?
at Investor's Business Daily, Inc. - Thu Dec 18
·Hospira, Inc. -- Moody's raises Hospira's outlook to positive from negative
- Thu Dec 18
·Salix Said to Get Sale Pressure as Reuters Reports Paulson Stake
at Bloomberg - Thu Dec 18
·Relmada Therapeutics Announces Results of Annual Shareholders Meeting
PR Newswire - Thu Dec 18
·Credit Suisse Raises Salix Pharmaceuticals Price Target
- Thu Dec 18
·Lannett Receives FDA Approval for Dorzolamide HCL with Timolol
Business Wire - Thu Dec 18
·Abbott to Present at J.P. Morgan Healthcare Conference
PR Newswire - Thu Dec 18
·NVN Therapeutics Launches EstraCool(TM) Dietary Supplement for Reduction of Menopausal Symptoms
GlobeNewswire - Thu Dec 18
·The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Catalyst Pharmaceutical Partners, Inc. -- CPRX
GlobeNewswire - Thu Dec 18
·The Medicines Company and SciClone Pharmaceuticals Establish Strategic Partnership for Two Cardiovascular Products in China
Business Wire - Thu Dec 18
·Celator® Pharmaceuticals Receives European Patent Allowance on Nanoparticle Delivery Technology
PR Newswire - Thu Dec 18
More Latest News...
Sponsor Results
Paperless Reg Docs
Secure online portal for clinical study start-up.
College Degree Online
Get Degree With $5,730 University or College Grant if Qualify. Act Now.
M/A/R/C Research
Full-service marketing research solutions customized to your needs
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?